Emile Voest
Led the DRUP trial giving off-label targeted drugs by genomic match, and developed organoid-based testing.
Emile Voest founded the Dutch DRUP precision oncology trial and the Hartwig Medical Foundation whole-genome sequencing programme, and developed patient-derived organoid co-cultures to test immunotherapy response.
| Title | Journal | Year |
|---|---|---|
| The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs | Nature | 2019 |
Pages like this
not linked directly; found by shared links- IdeaGrow tumour organoids together with the patient's own immune cells
Shares Netherlands Cancer Institute (NKI-AvL), Functional (ex vivo) drug testing, Patient-derived organoids.
- CompanyValius Sciences
Shares Functional (ex vivo) drug testing, Whole-exome & whole-genome sequencing.
- IdeaA bone marrow niche on a chip to study human dormancy
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
- IdeaA public atlas of drug-pair responses across a thousand patient-derived organoids
Shares Functional (ex vivo) drug testing, Patient-derived organoids, Whole-exome & whole-genome sequencing.
- IdeaTest drugs on freshly cut slices of the patient's own tumour
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
- InstitutionAtrium Health Wake Forest Baptist Comprehensive Cancer Center
Shares Functional (ex vivo) drug testing, Patient-derived organoids.
- InstitutionUMC Utrecht Cancer Center
Shares Netherlands Cancer Institute (NKI-AvL), Functional (ex vivo) drug testing, Patient-derived organoids.
- IdeaDigital twins for treatment selection, validated by predicting before observing
Shares Functional (ex vivo) drug testing, Patient-derived organoids.